Cingulate Inc. (CING) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Cingulate Inc.
Cingulate Inc. is led by CEO Shane J. Schaffer, employs 13 people, headquartered in US, publicly traded since 2021.
Cingulate Inc. (CING) stock trades at $4.98 with a market capitalization of $72.42M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.95, reflecting a net loss over the last twelve months, price-to-book of 1.10, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $3.16 and $11.89, and currently trades 58.1% below its 52-week high.
On profitability, Cingulate Inc. generates a return on equity (ROE) of -238.41% (negative, reflecting a net loss), return on capital employed of -101.98%.
Cingulate Inc. by the numbers, 2019–2025
Between 2019 and 2025 Cingulate Inc. reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit fell to $-22.0M.
On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-28.0M.
Borrowings rose from $2.0M to $9.0M, cash from operations was $-17.0M in the latest year, positive in 0 of the last 7.
Return on equity has averaged -236.7% over five years, and was -733.3% in the most recent year.
The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
Cingulate Inc. (CING) — frequently asked questions
What is Cingulate Inc. (CING) stock price today?
Cingulate Inc. (CING) is currently trading at $4.98, up 6.87% today.
What is CING P/E ratio?
Cingulate Inc.'s P/E ratio is -0.95. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is CING return on equity (ROE)?
Cingulate Inc.'s return on equity (ROE) is -238.41%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Cingulate Inc.'s market cap?
Cingulate Inc. has a market capitalization of $72.42M.
Does CING pay a dividend?
Cingulate Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does CING carry?
Cingulate Inc. has a debt-to-equity ratio of 0.27. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is CING's profit margin?
Cingulate Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is CING in?
Cingulate Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is CING listed on?
Cingulate Inc. trades on NASDAQ under the ticker CING.
What is CING's 52-week range?
Over the last year Cingulate Inc. has traded between $3.16 and $11.89.
Related Healthcare Stocks
Popular Stocks
Screens CING currently matches
On the figures above, Cingulate Inc. passes the filters for 3 of our ready-made screens, among them Day Gainers Stocks, Penny Stocks, Micro Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.